Biosimilar Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Other Applications), By Distribution Channel

The Biosimilar Hormones Market is valued at USD 7.9 billion in 2025 and is projected to grow at a CAGR of 22.8% to reach USD 50.3 billion by 2034. The Biosimilar Hormones Market is experiencing rob... もっと見る

出版社	出版年月	電子版価格	納期	言語
OG Analysis オージーアナリシス	2025年10月16日	US$3,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	通常3-4営業日以内	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

Table of Contents

Summary

The Biosimilar Hormones Market is valued at USD 7.9 billion in 2025 and is projected to grow at a CAGR of 22.8% to reach USD 50.3 billion by 2034.

The Biosimilar Hormones Market is experiencing robust growth as the healthcare industry increasingly recognizes the cost-saving potential of biosimilar alternatives. Biosimilar hormones, which are nearly identical to their reference biologic counterparts, provide an affordable and accessible solution for patients who require hormone therapies for conditions like diabetes, hormone deficiencies, and fertility treatments. The growing prevalence of these medical conditions has further driven demand for cost-effective treatments.

Key factors contributing to this market expansion include patent expirations of original biologic hormones, regulatory support for biosimilars, and rising acceptance among healthcare professionals and patients. Moreover, advancements in biotechnology and manufacturing processes have improved the quality, safety, and efficacy of biosimilar hormones, leading to increased trust and adoption.

Nevertheless, challenges such as the complexity of production, stringent regulatory requirements, and resistance from brand-loyal physicians and patients can slow market penetration. However, ongoing research, education campaigns, and regulatory harmonization are expected to address these hurdles and ensure continued growth.

Key Insights_ Biosimilar Hormones Market

1. Expanding portfolios of biosimilar hormone products.
2. Growing collaborations between biosimilar manufacturers and pharmaceutical companies.
3. Development of biosimilar hormones targeting a wider range of conditions.
4. Enhanced focus on patient education and awareness programs.
5. Increasing adoption of biosimilar hormones in emerging markets.

1. Cost savings compared to branded biologic hormones.
2. Expiring patents on key original biologic hormone products.
3. Rising prevalence of hormonal disorders and related conditions.
4. Supportive policies and streamlined regulatory pathways for biosimilars.

1. High production costs and technical challenges in manufacturing biosimilars.
2. Stringent regulatory requirements and lengthy approval processes.
3. Resistance from healthcare providers and patients loyal to branded biologics.
4. Limited awareness and education about the benefits of biosimilar hormones.

Biosimilar Hormones Market Segmentation

By Type

Teriparatide Biosimilars

Follitropin Alfa Biosimilars

Insulin Biosimilars

Somatropin Biosimilars

Other Types

By Application

Research & Biotechnology

Diagnostics

Biocatalysts

Therapeutics

Other Applications

By Distribution Channel

Hospital And Retail Pharmacy

Online Pharmacy/pharmacy

Specialty Clinics

Key Companies Analysed

Teva Pharmaceutical Industries Ltd.

Gedeon Richter Plc.

Intas Pharmaceuticals Ltd.

Biocon Limited

Mylan

Sanofi

Sandoz (Novartis)

LG Life Sciences

Ferring Pharmaceuticals

GC Pharma

Pfizer Inc.

Dr. Reddy's Laboratories

Amgen Inc.

Eli Lilly and Company

Celltrion Inc.

Samsungbioepis Co.Ltd

Merck & Co.

Biogen Inc.

Boehringer Ingelheim

Coherus BioSciences Inc.

Alvotech

BioXpress Therapeutics

Cipla Limited

Lupin Ltd.

Stada Arzneimittel AG

Torrent Pharmaceuticals

Zydus Cadila

Accord Healthcare

Hetero Drugs

Wockhardt

Biosimilar Hormones Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends. Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Biosimilar Hormones Market Competitive Intelligence

The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption. Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

North America — Biosimilar Hormones market data and outlook to 2034
- United States
- Canada
- Mexico
Europe — Biosimilar Hormones market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- BeNeLux
- Russia
- Sweden
Asia-Pacific — Biosimilar Hormones market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
Middle East and Africa — Biosimilar Hormones market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
South and Central America — Biosimilar Hormones market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru

* We can include data and analysis of additional countries on demand.

Research Methodology

This study combines primary inputs from industry experts across the Biosimilar Hormones value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

What is the current and forecast market size of the Biosimilar Hormones industry at global, regional, and country levels?

Which types, applications, and technologies present the highest growth potential?

How are supply chains adapting to geopolitical and economic shocks?

What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?

Who are the leading players, and how are their strategies evolving in the face of global uncertainty?

Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?

Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

Your Key Takeaways from the Biosimilar Hormones Market Report

Global Biosimilar Hormones market size and growth projections (CAGR), 2024-2034
Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Biosimilar Hormones trade, costs, and supply chains
Biosimilar Hormones market size, share, and outlook across 5 regions and 27 countries, 2023-2034
Biosimilar Hormones market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
Short- and long-term Biosimilar Hormones market trends, drivers, restraints, and opportunities
Porter’s Five Forces analysis, technological developments, and Biosimilar Hormones supply chain analysis
Biosimilar Hormones trade analysis, Biosimilar Hormones market price analysis, and Biosimilar Hormones supply/demand dynamics
Profiles of 5 leading companies—overview, key strategies, financials, and products
Latest Biosimilar Hormones market news and developments

Additional Support

With the purchase of this report, you will receive

An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
Complimentary report update to incorporate the latest available data and the impact of recent market developments.

* The updated report will be delivered within 3 working days

ページTOPに戻る

1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Global Biosimilar Hormones Market Summary, 2025
2.1 Biosimilar Hormones Industry Overview
2.1.1 Global Biosimilar Hormones Market Revenues (In US$ billion)
2.2 Biosimilar Hormones Market Scope
2.3 Research Methodology

3. Biosimilar Hormones Market Insights, 2024-2034
3.1 Biosimilar Hormones Market Drivers
3.2 Biosimilar Hormones Market Restraints
3.3 Biosimilar Hormones Market Opportunities
3.4 Biosimilar Hormones Market Challenges
3.5 Tariff Impact on Global Biosimilar Hormones Supply Chain Patterns

4. Biosimilar Hormones Market Analytics
4.1 Biosimilar Hormones Market Size and Share, Key Products, 2025 Vs 2034
4.2 Biosimilar Hormones Market Size and Share, Dominant Applications, 2025 Vs 2034
4.3 Biosimilar Hormones Market Size and Share, Leading End Uses, 2025 Vs 2034
4.4 Biosimilar Hormones Market Size and Share, High Growth Countries, 2025 Vs 2034
4.5 Five Forces Analysis for Global Biosimilar Hormones Market
4.5.1 Biosimilar Hormones Industry Attractiveness Index, 2025
4.5.2 Biosimilar Hormones Supplier Intelligence
4.5.3 Biosimilar Hormones Buyer Intelligence
4.5.4 Biosimilar Hormones Competition Intelligence
4.5.5 Biosimilar Hormones Product Alternatives and Substitutes Intelligence
4.5.6 Biosimilar Hormones Market Entry Intelligence

5. Global Biosimilar Hormones Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
5.1 World Biosimilar Hormones Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
5.1 Global Biosimilar Hormones Sales Outlook and CAGR Growth By Type, 2024- 2034 ($ billion)
5.2 Global Biosimilar Hormones Sales Outlook and CAGR Growth By Application, 2024- 2034 ($ billion)
5.3 Global Biosimilar Hormones Sales Outlook and CAGR Growth By Distribution Channel, 2024- 2034 ($ billion)
5.4 Global Biosimilar Hormones Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

6. Asia Pacific Biosimilar Hormones Industry Statistics – Market Size, Share, Competition and Outlook
6.1 Asia Pacific Biosimilar Hormones Market Insights, 2025
6.2 Asia Pacific Biosimilar Hormones Market Revenue Forecast By Type, 2024- 2034 (USD billion)
6.3 Asia Pacific Biosimilar Hormones Market Revenue Forecast By Application, 2024- 2034 (USD billion)
6.4 Asia Pacific Biosimilar Hormones Market Revenue Forecast By Distribution Channel, 2024- 2034 (USD billion)
6.5 Asia Pacific Biosimilar Hormones Market Revenue Forecast by Country, 2024- 2034 (USD billion)
6.5.1 China Biosimilar Hormones Market Size, Opportunities, Growth 2024- 2034
6.5.2 India Biosimilar Hormones Market Size, Opportunities, Growth 2024- 2034
6.5.3 Japan Biosimilar Hormones Market Size, Opportunities, Growth 2024- 2034
6.5.4 Australia Biosimilar Hormones Market Size, Opportunities, Growth 2024- 2034

7. Europe Biosimilar Hormones Market Data, Penetration, and Business Prospects to 2034
7.1 Europe Biosimilar Hormones Market Key Findings, 2025
7.2 Europe Biosimilar Hormones Market Size and Percentage Breakdown By Type, 2024- 2034 (USD billion)
7.3 Europe Biosimilar Hormones Market Size and Percentage Breakdown By Application, 2024- 2034 (USD billion)
7.4 Europe Biosimilar Hormones Market Size and Percentage Breakdown By Distribution Channel, 2024- 2034 (USD billion)
7.5 Europe Biosimilar Hormones Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
7.5.1 Germany Biosimilar Hormones Market Size, Trends, Growth Outlook to 2034
7.5.2 United Kingdom Biosimilar Hormones Market Size, Trends, Growth Outlook to 2034
7.5.2 France Biosimilar Hormones Market Size, Trends, Growth Outlook to 2034
7.5.2 Italy Biosimilar Hormones Market Size, Trends, Growth Outlook to 2034
7.5.2 Spain Biosimilar Hormones Market Size, Trends, Growth Outlook to 2034

8. North America Biosimilar Hormones Market Size, Growth Trends, and Future Prospects to 2034
8.1 North America Snapshot, 2025
8.2 North America Biosimilar Hormones Market Analysis and Outlook By Type, 2024- 2034 ($ billion)
8.3 North America Biosimilar Hormones Market Analysis and Outlook By Application, 2024- 2034 ($ billion)
8.4 North America Biosimilar Hormones Market Analysis and Outlook By Distribution Channel, 2024- 2034 ($ billion)
8.5 North America Biosimilar Hormones Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
8.5.1 United States Biosimilar Hormones Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Canada Biosimilar Hormones Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Mexico Biosimilar Hormones Market Size, Share, Growth Trends and Forecast, 2024- 2034

9. South and Central America Biosimilar Hormones Market Drivers, Challenges, and Future Prospects
9.1 Latin America Biosimilar Hormones Market Data, 2025
9.2 Latin America Biosimilar Hormones Market Future By Type, 2024- 2034 ($ billion)
9.3 Latin America Biosimilar Hormones Market Future By Application, 2024- 2034 ($ billion)
9.4 Latin America Biosimilar Hormones Market Future By Distribution Channel, 2024- 2034 ($ billion)
9.5 Latin America Biosimilar Hormones Market Future by Country, 2024- 2034 ($ billion)
9.5.1 Brazil Biosimilar Hormones Market Size, Share and Opportunities to 2034
9.5.2 Argentina Biosimilar Hormones Market Size, Share and Opportunities to 2034

10. Middle East Africa Biosimilar Hormones Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2025
10.2 Middle East Africa Biosimilar Hormones Market Statistics By Type, 2024- 2034 (USD billion)
10.3 Middle East Africa Biosimilar Hormones Market Statistics By Application, 2024- 2034 (USD billion)
10.4 Middle East Africa Biosimilar Hormones Market Statistics By Distribution Channel, 2024- 2034 (USD billion)
10.5 Middle East Africa Biosimilar Hormones Market Statistics by Country, 2024- 2034 (USD billion)
10.5.1 Middle East Biosimilar Hormones Market Value, Trends, Growth Forecasts to 2034
10.5.2 Africa Biosimilar Hormones Market Value, Trends, Growth Forecasts to 2034

11. Biosimilar Hormones Market Structure and Competitive Landscape
11.1 Key Companies in Biosimilar Hormones Industry
11.2 Biosimilar Hormones Business Overview
11.3 Biosimilar Hormones Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis

12 Appendix
12.1 Global Biosimilar Hormones Market Volume (Tons)
12.1 Global Biosimilar Hormones Trade and Price Analysis
12.2 Biosimilar Hormones Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Biosimilar Hormones Industry Report Sources and Methodology

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

OG Analysis社のヘルスケア・医薬品分野での最新刊レポート

本レポートと同じKEY WORD（biosimilar）の最新刊レポート

よくあるご質問

OG Analysis社はどのような調査会社ですか?

OG Analysisは、10年以上の専門知識を持ち、半導体、エネルギー、化学品、自動車、農業など多様な市場調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行っています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。